pmvpharma.comHealthcareFounded: 2013Funding to Date: $170.8MM
PMV is a biotechnology company dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.
View Enterprise Value for PMV Pharma.